Buscar
Sunshine Biopharma Inc
SBFMAñadir a la lista de seguimiento
1.150USD
-0.080-6.50%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
564.18KCap. mercado
PérdidaP/E TTM
Más Datos de Sunshine Biopharma Inc Compañía
Sunshine Biopharma Inc. is a pharmaceutical company engaged in offering and researching life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for the treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The Company operates two wholly owned subsidiaries: Nora Pharma Inc., which has a portfolio of pharmaceutical products consisting of various prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells nonprescription over-the-counter (OTC) products.
Información de Sunshine Biopharma Inc
Símbolo de cotizaciónSBFM
Nombre de la empresaSunshine Biopharma Inc
Fecha de salida a bolsaAug 15, 2008
Director ejecutivoSlilaty (Steve N)
Número de empleados52
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 15
Dirección333 Las Olas Way
CiudadFORT LAUDERDALE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal33301
Teléfono19543300684
Sitio Webhttps://www.sunshinebiopharma.com/
Símbolo de cotizaciónSBFM
Fecha de salida a bolsaAug 15, 2008
Director ejecutivoSlilaty (Steve N)
Ejecutivos de Sunshine Biopharma Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David Natan
Mr. David Natan
Independent Director
Independent Director
10.00K
--
Dr. Abderrazzak Merzouki
Dr. Abderrazzak Merzouki
Chief Operating Officer, Director
Chief Operating Officer, Director
59.00
--
Dr. Steve N. Slilaty
Dr. Steve N. Slilaty
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
6.00
--
Mr. Camille Sebaaly
Mr. Camille Sebaaly
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
6.00
--
Mr. Michel Roy
Mr. Michel Roy
Chief Commercial Officer
Chief Commercial Officer
1.00
--
Dr. Rabi Kiderchah, M.D.
Dr. Rabi Kiderchah, M.D.
Independent Director
Independent Director
--
--
Dr. Andrew M. Keller
Dr. Andrew M. Keller
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David Natan
Mr. David Natan
Independent Director
Independent Director
10.00K
--
Dr. Abderrazzak Merzouki
Dr. Abderrazzak Merzouki
Chief Operating Officer, Director
Chief Operating Officer, Director
59.00
--
Dr. Steve N. Slilaty
Dr. Steve N. Slilaty
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
6.00
--
Mr. Camille Sebaaly
Mr. Camille Sebaaly
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
6.00
--
Mr. Michel Roy
Mr. Michel Roy
Chief Commercial Officer
Chief Commercial Officer
1.00
--
Dr. Rabi Kiderchah, M.D.
Dr. Rabi Kiderchah, M.D.
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Sunshine Biopharma Inc?
Los cinco principales accionistas de Sunshine Biopharma Inc son: Mr. David Natan
¿Cuántas instituciones poseen acciones de Sunshine Biopharma Inc (SBFM)?
A fecha de 2026Q1, 35 instituciones poseen acciones de Sunshine Biopharma Inc, con un valor de mercado combinado de aproximadamente 253.46K, lo que representa el 5.17% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -345977.00.